BEAM

BEAM Operating Cash Flow (Statement)

-$359.38MTTM · USD

Period ending:

BEAM FY Cash from OperationsUSD
BEAM FY Cash from Operations2017-12-31: -$2.71M2018-12-31: -$20.30M2019-12-31: -$72.00M2020-12-31: -$95.74M2021-12-31: -$66.27M2022-12-31: $22.53M2023-12-31: -$149.20M2024-12-31: -$347.25M2025-12-31: -$345.10M$22.53M-$347.25M
2017-12-312025-12-31

Source: Financial Modeling Prep (FMP). Annual fiscal periods; reported in USD. Dates are period ends; a fiscal year may differ from a calendar year.

BEAM operating cash flow (statement) history

Net cash provided by operating activities. The available annual fiscal periods series contains 9 observations from Dec 31, 2017 to Dec 31, 2025.

Beam Therapeutics Inc Operating Cash Flow (Statement) — Annual fiscal periods (USD)
Period endingOperating Cash Flow (Statement) (USD)
-345,102,000
-347,246,000
-149,195,000
22,527,000
-66,268,000
-95,741,000
-72,003,000
-20,298,000
-2,707,000

Compare operating cash flow (statement)

All BEAM financial metrics · BEAM stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.